Mirae Asset Global Etfs Holdings Ltd. Alnylam Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 31,293 shares of ALNY stock, worth $8.68 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
31,293Holding current value
$8.68 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ALNY
# of Institutions
641Shares Held
108MCall Options Held
2.11MPut Options Held
2.04M-
Capital World Investors Los Angeles, CA15MShares$4.15 Billion0.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.5MShares$3.47 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.65 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA6.21MShares$1.72 Billion0.28% of portfolio
-
Baillie Gifford & CO4.89MShares$1.36 Billion1.03% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $34.1B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...